The Studies
We are profoundly grateful to the over 46,000 people participating in our landmark COVID-19 vaccine clinical trial. Because of them, we are now able to enroll volunteers in new studies that will help us learn more about the vaccine for specific groups of people.

THE COVID-FLU COMBINATION VACCINE STUDY
A Phase 1/2 research study for adults. Now enrolling.

THE COVID-RSV COMBINATION VACCINE STUDY
A Phase 1/2 research study for adults. Now enrolling.

The COVID-19 Vaccine Maternal Study
For expectant mothers 18 years old and over. No longer enrolling.

The COVID-19 Vaccine Pediatric Study
For children 6 months to 11 years old. No longer enrolling.

The COVID-19 Vaccine Study For Immunocompromised Patients
For adults and children 2-17. No longer enrolling.

The COVID-19 Vaccine Landmark Study
For individuals 12 years old and over. This study is ongoing but no longer enrolling new participants.

The COVID-19 Vaccine Study for the Omicron Variant
For unvaccinated and vaccinated 18-55 year olds. No longer enrolling.

THE COVID-19 VACCINE BOOSTER STUDY
For adults ages 18-30. No longer enrolling.

The COVID-19 Omicron Variant BA.4/BA.5 Targeted Vaccine Study
For previously vaccinated and boosted people 12 years and older. No longer enrolling.

THE OMICRON-TARGETED COVID-19 VACCINE STUDY FOR UNVACCINATED CHILDREN
For infants and children 6 months to less than 5 years old who have not received a COVID-19 vaccine. Now enrolling.

THE OMICRON-TARGETED COVID-19 VACCINE STUDY FOR PREVIOUSLY VACCINATED CHILDREN
For infants and children 6 months to less than 5 years old who have received 2 or 3 doses of the Pfizer & BioNTech COVID-19 vaccine Now enrolling.

THE PEDIATRIC OMICRON-TARGETED COVID-19 VACCINE STUDIES
For vaccinated and unvaccinated infants and children 6 months to less than 5 years old. Find the right study for your child. Now enrolling.